Biochemical and Biophysical Research Communications
Volume 453, Issue 2, 17 October 2014, Pages 254-267
ReviewBacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations
Under a Creative Commons license
open access
Abbreviations
3OC6-HSL
3-oxohexanoyl homoserine lactone
3OC12-HSL
N-(3-oxododecanoyl)-l-homoserine lactone
ABC
the ATP (adenosine triphosphate)-binding cassette superfamily
ABI-PP
AcrAB/MexAB-specific inhibitor of pyridopyrimidine derivative
AHL
N-acylhomoserine lactones
BRC
BmrR C terminus
C4-HSL
N-butyryl homoserine lactone
CCCP
carbonylcyanide-3-chlorophenylhydrazone
CTD
C-terminal domain
DARPin
designed ankyrin repeat protein
DBD
DNA binding domain
DDM
n-dodecyl-d-maltoside
DMT
drug/metabolite transporter superfamily
DNP
2,4-dinitrophenol
EPI
efflux pump inhibitor
Eb
ethidium bromide
EMSA
electrophoretic mobility shift assay
Et
ethidium
MATE
the multidrug and toxic compound extrusion family
MDCK
Madin–Darby canine kidney
MDR
multidrug resistance
MFS
the major facilitator superfamily
MIC
minimum inhibitory concentration
NMP
naphthylpiperazines
NP
nature product
Pf
proflavin
PAβN
phenyl-arginine beta-naphthylamide
PQS
2-heptyl-3-hydroxy-4-quinolone
QS
quorum sensing
RND
the resistance-nodulation-division family
SMR
the small multidrug resistance family
TCS
two component system
TPP
tetraphenylphosphonium
Keywords
Antibiotics
Multidrug resistance
Multidrug efflux pumps
Regulation
Physiology
Efflux pump inhibitors
Cited by (0)
- 1
These authors contribute equally.
Copyright © 2014 The Authors. Published by Elsevier Inc.